Abstract:BACKGROUND: Apolipoprotein E (apoE) genotypes play critical roles in lipid metabolism and are believed to influence risk for coronary heart disease (CHD). Despite many population studies, however, the impact of apoE polymorphism on risk for CHD remains uncertain.PURPOSE: To qualitatively and quantitatively assess the evidence regarding the relation of apoE polymorphism to CHD risk.DATA SOURCES: All relevant reports and references from original and review papers published from 1966 to January 2004.STUDY SELECTION: Predefined criteria were used to identify 48 relevant studies.DATA EXTRACTION: A summary database that contained variables of study design, study sample and ethnicity, sex, apoE genotypes, CHD end points, plasma lipid levels, and other CHD risk factors was developed.DATA SYNTHESIS: The authors qualitatively evaluated many potential sources of heterogeneity. To quantify the extent of heterogeneity and assess the consistency of apoE-CHD associations, stratified analyses were conducted using the classic random-effects model. To further incorporate uncertainty due to between-study variation, the pooled odds ratios (ORs) and 95% credible intervals (CrIs) were estimated by using a Bayesian hierarchical model. Finally, the robustness of the pooled estimates was tested in multiple sensitivity analyses. Compared with individuals with the epsilon3/3 genotype, carriers of the apoE epsilon4 allele had a 42% higher risk for CHD (OR, 1.42 [95% CrI, 1.26 to 1.61]). The epsilon2 allele had no significant association with CHD risk (OR, 0.98 [CrI, 0.66 to 1.46]).LIMITATIONS: This meta-analysis did not include unpublished data or studies published in languages other than English.CONCLUSIONS: Inadequate statistical power, differences in geographic and ethnic background, allele frequency, sex, CHD phenotypes, study design, and potential gene-environment interactions may have contributed to the conflicting results of previous studies. The apoE epsilon4 allele is a significant risk factor for CHD.

Clinical study of the association between apoE polymorphism and lipid metabolism of patients with CHD

Relationship between apolipoprotein E polymorphism and coronary heart disease

Association of Apolipoprotein E Polymorphism with Plasma Lipids and Atherosclerosis

Association Study of Apolipoprotein E Gene Polymorphisms with Geriatric Depression

E0300 Relationship of Polymorphism of Apolipoprotein E Alleles with Coronary Heart Disease

The effects of leucocytic and serum factors on fibrinogen biosynthesis in cultured hepatocytes.

Relationship Between Apolipoprotein E Gene Polymorphisms and Coronary Heart Disease

Concentration level and geographical distribution of nitrobenzene in Chinese surface waters.

E0301 the Relationship Between Apolipoprotein E Gene Polymorphisms and Coronary Atherosclerosis Disease in the Northern Chinese

Association of APOE polymorphisms with lipid-lowering efficacy of statins in atherosclerotic cardiovascular diseases.

[Study on Apoe Gene Polymorphism in Chinese Endogenous Hypertriglyceridemia].

Association of endothelial lipase gene Thr111Ile and Gly26Ser polymorphism with lipoprotein in patients with coronary heart disease

Apolipoprotein E Polymorphism in Northern Chinese Elderly Patients with Coronary Artery Disease

Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins

Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease

Association of Apolipoprotein E (APOE) Polymorphisms With Serological Lipid and Inflammatory Markers

[Effects of ApoE gene polymorphism on the efficacy of atorvastatin in the treatment of hyperlipidemia]

Apolipoprotein E Gene Polymorphisms Associated with Processing Speed and Executive Functions in Healthy Han Chinese

[Apolipoportein E Polymorphism, Serum Lipids and Apolipoproteins of 362 Han National Subjects in Chengdu Area].

Effect of Apolipoprotein E Gene Polymorphism on Lipid and Essential Hypertension

Association Between Cholesteryl Ester Transfer Protein-Taqib Polymorphism and Coronary Heart Disease